Previous Close | 14.20 |
Open | 21.04 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 430.00 |
Expire Date | 2024-08-16 |
Day's Range | 21.04 - 21.35 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
AI can now decode your brain activity—a fancy way of saying mind reading. Big tech companies like Meta (META) are backing research into this field, including products that can decode thoughts without requiring surgery. The big question: what does our world look like if big tech companies can read your mind? Tech companies are building off neurotech advancements in the medical world. Meta is backing a team of neuroscientists whose research uncovered nonsurgical ways to detect brain activity and speech to interpret your thoughts. In 2022, Apple (AAPL) also filed a patent for AirPods that uses EEG technology to measure biosignals and electrical activity of a user's brain. Noninvasive mind reading can be revolutionary in medicine for patients - it can also be used by big tech for consumer-facing products that put privacy at risk. Neurorights advocates believe our thoughts are the last piece of data we have left to ourselves. That’s why they are now fighting for legislation that would safeguard our mental privacy while tech companies continue funding brain-scanning research. If you’re going to future-proof your portfolio, you need to know what’s NEXT in the business of neurotechnology. In this series, Yahoo Finance will feature stories that give a glimpse at the future, and show how companies are making big moves today that will matter tomorrow. For more on our NEXT series, click here, and tune in to Yahoo Finance Live for more expert insight and the latest market action, Monday through Friday.
For decades, companies and researchers have been exploring implantable devices that can make the physically impossible a reality. These devices have been game-changers for people like Rodney, a patient based in Australia who has amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. ALS gradually inhibits all movement, including your ability to communicate. Rodney was able to communicate with me by using the Stentrode device: a tiny electrode that converts brain signals into physical actions. In other words, the device reads his mind, by allowing him to type without ever moving his hands. The Stentrode was developed by Synchron, a neurotech company backed by Jeff Bezos and Bill Gates. And it’s only the beginning. Tech companies like Meta (META) are building off neurotech advancements in the medical world, which could lead to more consumer facing neurotech products in the future. If you’re going to future-proof your portfolio, you need to know what’s NEXT in the business of neurotechnology. In this series, Yahoo Finance will feature stories that give a glimpse at the future, and show how companies are making big moves today that will matter tomorrow. For more on our NEXT series, click here, and tune in to Yahoo Finance Live for more expert insight and the latest market action, Monday through Friday.
In this article, we will take a detailed look at Billionaire Ken Fisher Loves These 10 AI Stocks. If you want to skip our detailed analysis and see the top 5 stocks in this list, click Billionaire Ken Fisher Loves These 5 AI Stocks. Earlier this month, billionaire Ken Fisher, while talking to Bloomberg, said that in his career […]